A Systematic Review and Meta-Analysis of the Incidence of Sensorineural Hearing Loss in Head and Neck Cancer Patients Undergoing Chemoradiotherapy Compared to Radiotherapy - Scorecard - MDSpire
Advertisement
A Systematic Review and Meta-Analysis of the Incidence of Sensorineural Hearing Loss in Head and Neck Cancer Patients Undergoing Chemoradiotherapy Compared to Radiotherapy
Clinical Scorecard: A Systematic Review and Meta-Analysis of the Incidence of Sensorineural Hearing Loss in Head and Neck Cancer Patients Undergoing Chemoradiotherapy Compared to Radiotherapy
At a Glance
Category
Detail
Condition
Sensorineural Hearing Loss in Head and Neck Cancer Patients
Key Mechanisms
Chemoradiotherapy, particularly with cisplatin, increases the risk of sensorineural hearing loss compared to radiotherapy alone.
Target Population
Patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy.
Care Setting
Oncology clinics and hospitals providing cancer treatment.
Key Highlights
Chemoradiotherapy has a higher incidence of sensorineural hearing loss compared to radiotherapy alone.
82.5% of patients undergoing chemoradiotherapy experienced sensorineural hearing loss.
25.7% incidence of sensorineural hearing loss observed in patients undergoing radiotherapy.
Guideline-Based Recommendations
Diagnosis
Audiometric assessment to determine hearing thresholds.
Management
Consideration of hearing preservation strategies in treatment planning.
Monitoring & Follow-up
Regular audiometric evaluations during and after treatment.
Risks
Increased risk of sensorineural hearing loss with cisplatin-based chemoradiotherapy.
Patient & Prescribing Data
Adults with advanced head and neck cancer.
Multimodal treatment approaches are necessary for advanced cases, with careful monitoring for hearing loss.
Clinical Best Practices
Utilize a multidisciplinary approach for managing head and neck cancer.
Implement strategies to mitigate hearing loss in patients receiving chemoradiotherapy.
Cancer care today is more advanced, more personalized, and more effective than ever before, and Radiation Oncology plays a central role in that progress.
